Relmada Therapeutics (RLMD) Total Liabilities (2012 - 2026)
Relmada Therapeutics (RLMD) recorded Total Liabilities of $12.5 million in Q2 2026, up 142.0% from $5.17 million a year earlier but down 24.8% from the prior quarter.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Total Liabilities (2012 - 2026) Analysis & Trends
At the end of FY2025, Relmada Therapeutics reported Total Liabilities of $7.49 million, down 27.2% from FY2024.
- Annual Total Liabilities has declined for four straight years, with a five-year compound annual growth rate of -9.9% (FY2020 to FY2025).
- Across earlier years, Total Liabilities came in at $10.3 million in FY2024 (-15.6%), $12.19 million in FY2023 (-2.2%), $12.47 million in FY2022 (-17.2%) and $15.06 million in FY2021 (+19.5%).
- Quarterly Total Liabilities has ranged from $5.17 million in Q2 2025 to $20.78 million in Q3 2022 over the past five years.
- On a year-over-year basis, Total Liabilities rose in two of the last eight quarters, with growth averaging 22.0%.
- Peak year-over-year performance for Total Liabilities in the last five years was growth of 438.4% in Q3 2021, against a decline of 59.5% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $16.63 million (Q1 2026), $7.49 million (Q4 2025) and $5.41 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 116.09 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 141.05 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 87.82 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 80.09 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 65.46 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 83.95 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 37.53 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 115.64 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 7.18 Bn |
| 10 | Relmada Therapeutics | 404.28 Mn | 404.28 Mn | - | 12.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.50 Mn |
| Mar 31, 2026 | 16.63 Mn |
| Dec 31, 2025 | 7.49 Mn |
| Sep 30, 2025 | 5.41 Mn |
| Jun 30, 2025 | 5.17 Mn |
| Mar 31, 2025 | 5.24 Mn |
| Dec 31, 2024 | 10.30 Mn |
| Sep 30, 2024 | 8.10 Mn |
| Jun 30, 2024 | 9.54 Mn |
| Mar 31, 2024 | 12.36 Mn |
| Dec 31, 2023 | 12.19 Mn |
| Sep 30, 2023 | 8.42 Mn |
| Jun 30, 2023 | 10.70 Mn |
| Mar 31, 2023 | 10.10 Mn |
| Dec 31, 2022 | 12.47 Mn |
| Sep 30, 2022 | 20.78 Mn |
| Jun 30, 2022 | 18.92 Mn |
| Mar 31, 2022 | 15.41 Mn |
| Dec 31, 2021 | 15.06 Mn |
| Sep 30, 2021 | 18.25 Mn |
API Access
Relmada Therapeutics Total Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-liabilities&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-liabilities", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-liabilities&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();